Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Substance use disorder continues to be a pervasive health challenge in the U.S. | Carrum Health, a company that established ...

Across Ontario, the toxic drug supply killed 290 people in July 2024 alone. These tragic deaths stem from government inaction ...

Researchers who evaluated the Madison Area Recovery Initiative (MARI) found that non-violent offenders who were given a ...

Compared against the leading AI models for drug repurposing ... drugs have acquired at least one additional indication for treatment following initial approval, and many have acquired tens ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

Houston Methodist researchers have developed an advanced mathematical model that predicts ... identifying novel drug combinations that could significantly improve treatment efficacy and ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...

Emory wins $8.3 million grant from the National Institutes for Health that will support a project that aims to develop novel ...

Compared against the leading AI models for drug repurposing ... drugs have acquired at least one additional indication for treatment following initial approval, and many have acquired tens ...

A recent study has shown an experimental drug, called RK-33, holds promise in treating breast cancer with bone metastases, ...